Antitrust officials gave CVS the green light on Wednesday to purchase Aetna, the nation’s third-largest health insurance company, in a $69 billion deal that could potentially transform the health care industry and change how millions of Americans receive basic medical services.
The Justice Department approved the deal on the condition that the companies sell off Aetna’s Medicare Part D prescription drug business.